This site is intended for health professionals only!

Published on 23 November 2011

Share this story:
Twitter
LinkedIn
RELATED ARTICLES
Diabetes drug reduces amputations
BioMérieux to gradually close site in Netherlands
Appointment of Mark Borthwick to chair of UKCPA
Xaluprine in acute lymphoblastic leukaemia
Multimedia technology for cancer patients

Understanding compassionate-use programmes

teaser

 

Prof Paola Minghetti, PhD  

Professor of Pharmaceutical Sciences, Universit



Most read

1
Feedback: Automation systems in your hospital
2
Helapet introduce new, improved 20mm Vented Vial Adapter
3
User-friendly osteoporosis therapy launched
4
Merck agrees huge Vioxx settlement
5
Janssen-Cilag’s Stelara approved by NICE



Latest Issue

Read the latest issue >
Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe
Share this story:
Twitter
LinkedIn
RELATED ARTICLES
Two date rape drugs banned in France
Risk management in pharmacotherapy
Glucosamine supplement could lower heart disease risk, study shows
New antibacterial drug unveiled at leading European microbiology congress
Phase I/II ARADES trial of a new generation anti-androgen